LUCD — Lucid Diagnostics Share News
0.000.00%
Last trade - 00:00- $206.03m
- $213.49m
- $4.71m
Lucid Diagnostics Inc expected to post a loss of 38 cents a share - Earnings Preview
Focus: Elon Musk's challenge: Stay ahead of the competition
Brief: Pavmed Partners With Novosound On Ultrasound Imaging Technology
Brief: Lucid Diagnostics Inc Files For Mixed Shelf Offering Of Up To $125 Million - SEC Filing
U.S. RESEARCH ROUNDUP-Analog Devices, Mettler-Toledo International, Travelcenters of America
U.S. RESEARCH ROUNDUP-Abbvie, Eli Lilly, Vroom
Brief: PAVmed Provides Third Quarter 2022 Financial Results
Lucid Diagnostics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Lucid Diagnostics Inc Reports Quarterly Adjusted Loss Per Share Of $0.28
Lucid Diagnostics Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: Lucid Diagnostics Commences Production Of Esocheck Devices With High-Volume Manufacturer
U.S. RESEARCH ROUNDUP-Duckhorn Portfolio, Nordstrom, Tesla
Brief: Lucid Diagnostics Reports Q2 GAAP Loss Per Share $0.41
Brief: Lucid Diagnostics Launches Stage II Lucid Test Center Expansion In California, Texas, Florida, And Ohio
Brief: Lucid Diagnostics Says Co's Laboratory Executes Four New Participating Provider Agreements
Brief: Lucid Diagnostics Files For Potential Offer And Sale Of Up To 15 Mln Shares By CF Principal Investments
Brief: Lucid Diagnostics Reports Q1 Preliminary Adjusted Loss Per Share Of $0.23
Lucid Diagnostics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement With MediNcrease Health Plans